gemcitabine + docetaxel

DRUG2 trials

Sponsors

Mario Negri Institute for Pharmacological Research, University of Arizona

Conditions

LeiomyosarcomaUrinary Bladder Cancer

Phase 2

Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma

CompletedNCT02249702

Mario Negri Institute for Pharmacological ResearchLeiomyosarcoma

Start: 2010-04-30End: 2017-04-30Updated: 2017-12-06

Intravesical Gem/Doce in Patients With NMIBC

Active, not recruitingNCT05644041

University of ArizonaUrinary Bladder Cancer

Start: 2023-03-01End: 2027-01-31Updated: 2026-07-13